At Shree Ganesh Remedies Limited (SGRL), we believe that Research and Technology (R&T) development is essential to our continuous innovation and success. We consider it a beneficial long-term investment for future capabilities that would help further on new and improvised products as well as processes. Delivering on our vision and commitment, we recently established a dedicated state-of-the-art Research Centre as well as a new Pilot Plant, which is managed by a team of experienced scientists, chemistry experts, and engineers.
Year 2022-2023 been a milestone for our R&D division. We invested in the development of our new R&D facility comprising 18 fume hoods (a three-fold increase from our earlier reaction research capacity), allowing us to cater to the increasing demand in the Fine & Specialty chemicals and Advanced Pharmaceutical Intermediates market. The R&D team whilst developing new products also concentrates on the improvement of the existing products and processes. Our commitment towards Research & Development would be placed in a top priority as we believe that it is one of the most important investments we can make in for our future.
The new enhanced R&D center demonstrates our commitment to innovation and our willingness to invest in better sustainable processes. We believe that this investment will pay off in the long run, as it will help us to stay ahead of the competition and to bring new and exciting products to market.
Quality & Analytical FacilitiesSGRL’s new pilot plant facilities are now able to create simulations to demonstrate the processes at the pilot plant stage, identifying the product at early stages in consonance with the scientists working on the chemical process development. This is allowing us to streamline the process of technology and knowledge transfer from R&T to our commercial sites for faster production, better lead times, and better utilization of our capacity.